Basics AN2 Therapeutics, Inc. IPO Date: March 25, 2022 Sector: Healthcare Industry: Biotech Market Cap: $33.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 4.07% Avg Daily Range (30 D): $0.03 | 2.21% Avg Daily Range (90 D): $0.03 | 2.34% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 173 Avg Trade Size (Sh.) (30 D): 368 Avg Trade Size (Sh.) (90 D): 601 Institutional Trades Total Inst.Trades: 53 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $2.9M Avg Inst. Trade (90 D): $2.9M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.45M Avg Closing Trade (30 D): $.54M Avg Closing Trade (90 D): $.54M Avg Closing Volume: 225.92K     News May 21, 2024 @ 1:35 PM Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic... Source: Zacks Equity Research Feb 13, 2024 @ 1:08 PM ZoomInfo Technologies To Rally Around 50%? Here Ar... Source: Avi Kapoor Feb 12, 2024 @ 7:15 PM Nasdaq Edges Lower; ContextLogic Shares Surge Source: Avi Kapoor Feb 12, 2024 @ 6:07 PM Why Big Lots Shares Are Trading Lower By Around 31... Source: Avi Kapoor Feb 12, 2024 @ 5:30 PM Dow Surges Over 150 Points; Gilead Sciences To Acq... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.25 $-.21 $-.35 Diluted EPS $-1.25 $-.21 $-.35 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -37.38M $ -6.46M $ -10.65M Operating Income / Loss $ -41.37M $ -7.22M $ -11.54M Cost of Revenue $ $ $ Net Cash Flow $ -8.55M $ -1.77M $ -1.37M PE Ratio